Nancy Lee, MD
Enriched profileRadiation Oncologist & Early Drug Development Specialist · Memorial Sloan Kettering Cancer Center
Nancy Lee is Radiation Oncologist & Early Drug Development Specialist at Memorial Sloan Kettering Cancer Center. ClinicalTrials.gov lists 20 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 15 Nov 2026
Nancy Lee, MD, is Radiation Oncologist & Early Drug Development Specialist at Memorial Sloan Kettering Cancer Center. It also documents an investigator role on 20 registered clinical trials, industry payments reported by 11 companies, 3 NIH-funded awards (2012–2026).
- Top research focus: Head & Neck Cancer
- 20 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 15 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Vice-chair
Department of Radiation Oncology, Memorial Sloan Kettering
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
- Principal investigator
RTOG national trial of IMRT for nasopharyngeal cancer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - Series editor
Practical Guides in Radiation Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 20 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Industry payments
Updated 13 Nov 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202535 payments$67,877openpaymentsdata.cms.gov ↗
- Janssen Research & Development, LLCProgram year20251 payment
- Merck Sharp & Dohme LLCProgram year20248 payments$38,388openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Opioid Agonist100%Oxycodone Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Nov 2026
3 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
Sloan-Kettering Inst Can Research
FY2026$1,055,000UG1CA233290 - A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
Sloan-Kettering Inst Can Research
FY2026$777,228R01CA238392 - Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
Sloan-Kettering Inst Can Research
FY2025$1,185,142UG1CA233290
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- MD
University of Medicine and Dentistry of New Jersey
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Editorial & leadership roles
journal and society appointments- Editorial board member
Journal of Radiation Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - Co-author
Cancer Immunotherapy Guidelines for Head and Neck Cancer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - Member
Head and Neck Cancer Working Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - Scientific Advisory Board member
Leo Cancer Care
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →leocancercare.com ↗ - Core Committee Member
Head and Neck Cancer Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nrgoncology.org ↗ - Partnerships & Finance Committee member
Head & Neck Cancer International Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →headneckcig.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Ladanyi, MD
Memorial Sloan Kettering Cancer Center
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Murray Brennan, MD
Memorial Sloan Kettering Cancer Center
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington